A Mobile Executive Functioning Intervention for Momentary Craving in Opioid Use Disorders
NCT05086835 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2022-06-10
Summary
Even when treated with methadone or buprenorphine maintenance, many people with opioid use disorder (OUD) continue to experience craving. Among both users of heroin and users of prescription opioids, mounting evidence shows that craving predicts return to use and undermines existing treatments for OUD, thus, the development of new interventions to reduce craving is a priority for addressing the opioid crisis (NIH HEAL Initiative Research Plan, 2019). Deficits in executive functioning, particularly working memory, are a central mechanism that undermines the ability to inhibit craving. Laboratory studies in non-clinical samples show that engaging in working memory tasks before or during a craving induction increases the ability to resist craving.
This suggests that people with OUD may benefit from engaging in working memory tasks at the specific moment when craving occurs. Although previous research shows that working memory "training" does not improve clinical outcomes in OUD, these studies have not delivered training at the moment that craving actually occurs in daily life. Thus, engaging in working memory tasks at the moment that craving occurs could presumably help individuals with OUD to manage this persistent symptom, but this has not been tested.
Further, studies using Ecological Momentary Assessment (EMA) methods show that people with OUD can accurately track moment-to-moment fluctuations in craving in their daily lives, suggesting that it may be feasible to deliver interventions for craving in the moment when craving is reported. This study will test the efficacy of embedding a mobile cognitive intervention into an EMA design in people with OUD. Using the NIH Stage Model of Intervention Development, Stage 1A of this project will optimize a working memory intervention based on iterative feedback from a sample of people with OUD (n = 20), in preparation for a Stage 1B trial using a randomized design. In this trial, participants with OUDs (n = 60) will complete a two-week EMA study in which they complete smartphone-based assessments of craving five times daily. When craving is reported, a mobile application containing the working memory intervention will activate. Half of the participants will complete the intervention, while half will complete a control task. At the conclusion of the trial, participants will be granted unrestricted access to the intervention during a feasibility phase. Outcomes include change in momentary craving, change in working memory performance, and feasibility and acceptability, including use of the intervention during follow-up. Substance use will also be assessed. This project supports the applicant's goal of leveraging cognitive mechanisms to conduct treatment development research for OUD. The applicant will receive training in the etiology and treatment of OUD, craving, mobile intervention development and human-centered design of interventions, and analysis of intensive longitudinal data. With its emphasis on modifying cognitive processes at the moment of craving, using mobile devices in patients' daily lives, this project has the potential to reveal new pathways for addressing a significant predictor of relapse in OUD.
Conditions
Interventions
- OTHER
-
Working Memory Task
A smartphone-based visual-spatial working memory task that will be optimized in the Stage 1A phase of this study.
- OTHER
-
Visual Search Task
A smartphone-based visual search task that will be optimized in the Stage 1A phase of this study.
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
Mclean Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-14
- Primary Completion
- 2022-03-01
- Completion
- 2022-03-01
Countries
- United States
Study Locations
More Related Trials
-
Activity Monitoring Assessment of Opiate Withdrawal - 4
NCT00000335 ·Status: COMPLETED ·Phase: PHASE2
-
HMP for Addictions Study
NCT06063499 ·Status: WITHDRAWN ·Phase: NA
-
Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder
NCT04850664 ·Status: UNKNOWN ·Phase: PHASE2
-
Memantine-enhanced Buprenorphine Treatment for Opioid-dependent Young Adults
NCT01052662 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Adversity, Brain and Opioid Use Study
NCT06355778 ·Status: RECRUITING ·Phase: NA
-
Mindfulness-Based Relapse Prevention for Methadone Maintenance
NCT03882125 ·Status: COMPLETED ·Phase: NA
-
Memantine and Naltrexone Treatment for Opioid Dependence
NCT00125515 ·Status: COMPLETED ·Phase: PHASE2
-
Neurocognitive Effects of Opiate Agonist Treatment
NCT01733693 ·Status: COMPLETED ·Phase: PHASE4
-
Buprenorphine Maintenance for Opioid-Addicted Persons in Jail and Post-Release
NCT00367302 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Neurofeedback in Individuals With Substance Use Disorders
NCT04188288 ·Status: TERMINATED ·Phase: NA
-
Developing a Smartphone Application to Support Veteran Opioid Use Disorder Treatment
NCT06454903 ·Status: RECRUITING ·Phase: NA
-
Following Outcomes Remotely Within Addiction Recovery Domains
NCT06001437 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Rescue Protocol - 2
NCT00000206 ·Status: COMPLETED ·Phase: PHASE2
-
Integrating Brain, Neurocognitive, and Computational Tools in OUD
NCT06136247 ·Status: RECRUITING
-
Cognitive Function and Pain Threshold in People Who Are Methadone Maintained
NCT04027166 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study of Buprenorphine Maintenance Treatment for Opioid Dependence in Primary Care
NCT00471042 ·Status: COMPLETED
-
Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients
NCT00879996 ·Status: COMPLETED ·Phase: PHASE4
-
The Impact of Methadone Maintenance Therapy on Food Reward Processing in Opioid Dependence
NCT03575273 ·Status: COMPLETED ·Phase: NA
-
Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20
NCT00000238 ·Status: COMPLETED ·Phase: PHASE2
-
Diversion to Treatment for Injection Drug Users Arrested for Possession of Heroin
NCT01723527 ·Status: COMPLETED ·Phase: PHASE1
-
Buprenorphine Maintenance Protocol - 1
NCT00000205 ·Status: COMPLETED ·Phase: PHASE3
-
OUD (Opioid Use Disorder) Target Trial
NCT06585709 ·Status: RECRUITING ·Phase: NA
-
Comparison of Buprenorphine and Methadone - 3
NCT00000334 ·Status: COMPLETED ·Phase: PHASE2
-
Improving Office Based Treatment of Opioid Use Disorder With Technology
NCT03586466 ·Status: UNKNOWN ·Phase: NA
-
Contingency Management for Opioid and Stimulant Use Disorders in Primary Care
NCT05288751 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA